Pharmaceuticals - Community Register


List of refusals for human medicinal products


Product name: Zelnorm
Active substance: tegaserod
Indication: indicated for the repeated symptomatic short-term treatment of Irritable Bowel Syndrome in women whose predominant bowel habit is constipation (IBS-C)
Marketing Authorisation Holder: Novartis Europharm Limited

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/05/2006 Centralised - Refusal of marketing authorisation EMEA/H/C/621 (2006)2116 of 19/05/2006